Search | eNauka

Research outputs

High Dose Imatinib Induction Therapy (800 mg/day, 6 Months) In Pre-Treated Chronic Phase CML Patients Improves Cytogenetic and Molecular Responses but Does Not Improve Overall and Progression Free Survival - Final Results of the CELSG Phase III CML11 "IST [2010]

Perzeri, Andreas L; ...; Bogdanovic, Andrija D ; ...; (broj, koautora 20)

Surgery with Turoctocog Alfa: Efficacy and Safety in Bleeding Prevention During Surgical Procedures - Results From the guardian (TM) Trials [2012]

Santagostino, Elena; Lentz, SR; Misgav, M; Brand, B; Chowdary, Pratima; Savic, Aleksandar D ; Kilinc, Yurdanur; Tuddenham, Edward GD; Lindblom, A

Foxo3 transcription factor regulates oxidative stress in in vivo erythropoiesis. [2006]

Marinković, Dragan ; Zhang, Xin; Brugnara, Carlo; Ghaffari, Saghi

Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells [2004]

Beleslin-Čokić, Bojana B. ; Čokić, Vladan ; Yu, Xiaobing; Weksler, Babette B.; Schechter, Alan N.; Noguchi, Constance Tom

Estimation of cell membrane alteration after drug treatment by LDH release [2003]

Jurisic, Vladimir B

Oral treatment with PBI-1402 increases hemoglobin level and red blood cell count: A novel approach to treating chemotherapy-induced anemia. [2007]

Gagnon, Lyric; Barabe, Jean; Penney, Christopher; Roy, Denis-Claude; Kovcin, Vladimir N; Bosnjak, Snezana M; Laurin, Pierre

Erythropoietin signaling and response in vascular smooth muscle cells. [2007]

Beleslin-Čokić, Bojana B. ; Čokić, Vladan P. ; Gojkovic-Bukarica, Ljiljana C ; Noguchi, Constance Tom

Thrombotic and Bleeding Complications in Patients with Chronic Lymphocytic Leukemia and Severe COVID-19: A Study of Eric, the European Research Initiative on CLL [2022]

Antić, Darko A. ; Milić, Nataša M. ; ...; Otašević, Vladimir; Rajović, Nina Z. ; ...; Mihaljević, Biljana S. ; Milošević, Ivana D. ; ...; Tomić, Kristina;

...; Vuković, Vojin M. ; ...; (broj koautora 101);

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia [2012]

Robak, Tadeusz; Windyga, Jerzy; Trelinski, Jacek; von, Depka Prondzinski Mario; Giagounidis, Aristoteles; Doyen, Chantal; Janssens, Ann; Álvarez-Román, María Teresa; Jarque, Isidro; Loscertales, Javier;

Rus, Gloria Pérez; Hellmann, Andrzej; Jêdrzejczak, Wiesław Wiktor; Kuliczkowski, Kazimierz; Golubovic, Lana M.; Celeketic, Dusica; Cucuianu, Andrei; Gheorghita, Emanuil; Lazaroiu, Mihaela; Shpilberg, Ofer; Attias, Dina; Karyagina, Elena; Svetlana, Kalinina; Vilchevska, Kateryna; Cooper, Nichola; Talks, Kate; Prabhu, Mukhyaprana; Sripada, Prasad; Bharadwaj, T. P. R.; Næsted, Henrik; Skartved, Niels J. Ø.; Frandsen, Torben P.; Flensburg, Mimi F.; Andersen, Peter S.; Petersen, Jørgen;

Phase 3 Study of Teclistamab (Tec) in Combination with Lenalidomide (Len) and Tec Alone Versus Len Alone in Newly Diagnosed Multiple Myeloma (NDMM) As Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT): Safety Run-in (SRI) Results from the Majestec-4/EMN30 Trial [2024]

Zamagni, Elena; ...; Bila, Jelena S. ; ...; (broj koautora 53)